| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Oramed Pharmaceuticals Inc. (ORMP) have been net sellers, shedding 50,000 shares worth roughly $226K on balance.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 4.14M | $17.10M | - | |
| Other | 1.55M | $6.40M | - | |
| COO | 1.33M | $5.49M | - | |
| CFO | 861.1K | $3.56M | - | |
| Dir | 168.0K | $693.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 19, 2015 | Nadav Kidron67 | President and CEO | Buy | 2,600 | $3.88 | $10,082.00 | +0.3% |